Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992688 · ClinicalTrials.gov registry record · NA
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
A NA study of Blood Pressure and Weight Gain, sponsored by Arkansas Children's Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT05992688: Recruiting NA study of Blood Pressure and Weight Gain, sponsored by Arkansas Children's Hospital Research Institute.
NCT05992688 is a NA study of Blood Pressure and Weight Gain that is actively recruiting participants, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 150 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05992688, a NA study of Blood Pressure and Weight Gain, is actively recruiting participants, sponsored by Arkansas Children's Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an 8 to14-week three-arm randomized controlled in children 8 to 12 years old. The main purpose of the study is to evaluate if stevia has benefits for weight control and metabolic function relative to caloric sweeteners, and whether it provides benefits in this regard similar to water.
Primary Outcome
The change in BMI z-score will be calculated: BMI z-score at completion of the study minus BMI z-score at baseline
Conditions Studied
Interventions
- OTHER Sucrose sweetened beverage
- OTHER Stevia sweetened beverages
- OTHER Calorie free flavored water beverage
Study Locations (2)
Arkansas
- Arkansas Children's Nutrition Center - Little Rock
- Arkansas Children's Nutrition Center - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT05992688 shows while recruiting
NCT05992688 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (47% lower).
The record links to 5 conditions, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Sucrose sweetened beverage is the first listed.
NCT05992688 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05992688 about?
NCT05992688 is a clinical study titled "The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)". This is an 8 to14-week three-arm randomized controlled in children 8 to 12 years old. The main purpose of the study is to evaluate if stevia has benefits for weight control and metabolic function relative to caloric sweeteners, and whether it provides benefits in this regard similar to water.
What is the current status of trial NCT05992688?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-09-19. Estimated completion is 2026-11-30.
What conditions does trial NCT05992688 study?
This clinical trial studies the following conditions: Blood Pressure, Weight Gain, Insulin Sensitivity, Adiposity, Lipoproteins.
What interventions are being tested in trial NCT05992688?
The interventions under investigation include: Sucrose sweetened beverage (OTHER), Stevia sweetened beverages (OTHER), Calorie free flavored water beverage (OTHER).
Who is sponsoring clinical trial NCT05992688?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992688 being conducted?
This trial has 2 study locations across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05992688's enrollment target sits among peer trials
150 30th of 101 higher than 72 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI